{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:15:42Z","timestamp":1789773342431,"version":"4.0.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,10,21]],"date-time":"2009-10-21T00:00:00Z","timestamp":1256083200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s00277-009-0841-4","type":"journal-article","created":{"date-parts":[[2009,10,20]],"date-time":"2009-10-20T19:48:12Z","timestamp":1256068092000},"page":"391-397","source":"Crossref","is-referenced-by-count":60,"title":["Serum albumin level is a significant prognostic factor reflecting disease severity in symptomatic multiple myeloma"],"prefix":"10.1007","volume":"89","author":[{"given":"Jeong Eun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhoon","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-We","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Shin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheolwon","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,10,21]]},"reference":[{"key":"841_CR1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","volume":"121","author":"The International Myeloma Working Group","year":"2003","unstructured":"The International Myeloma Working Group (2003) Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 121:749\u2013757","journal-title":"Br J Haematol"},{"key":"841_CR2","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/1097-0142(197510)36:4<1192::AID-CNCR2820360403>3.0.CO;2-I","volume":"36","author":"R Alexanian","year":"1975","unstructured":"Alexanian R, Balcerzak S, Bonnet JD, Gehan EA, Haut A, Hewlett JS, Monto RW (1975) Prognostic factors in multiple myeloma. Cancer 36:1192\u20131201","journal-title":"Cancer"},{"key":"841_CR3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2141.1983.tb02158.x","volume":"55","author":"R Bataille","year":"1983","unstructured":"Bataille R, Durie BG, Grenier J (1983) Serum beta2 microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging. Br J Haematol 55:439\u2013447","journal-title":"Br J Haematol"},{"key":"841_CR4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1200\/JCO.1986.4.1.80","volume":"4","author":"R Bataille","year":"1986","unstructured":"Bataille R, Durie BG, Grenier J, Sany J (1986) Prognostic factors and staging in multiple myeloma: a reappraisal. J Clin Oncol 4:80\u201387","journal-title":"J Clin Oncol"},{"key":"841_CR5","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1172\/JCI114392","volume":"84","author":"R Bataille","year":"1989","unstructured":"Bataille R, Jourdan M, Zhang XG, Klein B (1989) Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias. J Clin Invest 84:2008\u20132011","journal-title":"J Clin Invest"},{"key":"841_CR6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1600-0609.1985.tb00794.x","volume":"35","author":"OW Bjerrum","year":"1985","unstructured":"Bjerrum OW, Plesner T (1985) Beta-2-microglobulin: a valuable parameter of stage, prognosis and response to treatment in myelomatosis. Scand J Haematol 35:22\u201325","journal-title":"Scand J Haematol"},{"key":"841_CR7","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2141.1990.tb07790.x","volume":"75","author":"J Cuzick","year":"1990","unstructured":"Cuzick J, De Stavola BL, Cooper EH, Chapman C, MacLennan IC (1990) Long-term prognostic value of serum beta 2 microglobulin in myelomatosis. Br J Haematol 75:506\u2013510","journal-title":"Br J Haematol"},{"key":"841_CR8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/pgmj.47.552.635","volume":"47","author":"AA Dawson","year":"1971","unstructured":"Dawson AA, Ogston D (1971) Factors influencing the prognosis in myelomatosis. Postgrad Med J 47:635\u2013638","journal-title":"Postgrad Med J"},{"key":"841_CR9","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","volume":"36","author":"BG Durie","year":"1975","unstructured":"Durie BG, Salmon SE (1975) A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 36:842\u2013854","journal-title":"Cancer"},{"key":"841_CR10","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1182\/blood.V75.4.823.823","volume":"75","author":"BG Durie","year":"1990","unstructured":"Durie BG, Stock-Novack D, Salmon SE, Finley P, Beckord J, Crowley J, Coltman CA (1990) Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study. Blood 75:823\u2013830","journal-title":"Blood"},{"key":"841_CR11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev.med.51.1.245","volume":"51","author":"WB Ershler","year":"2000","unstructured":"Ershler WB, Keller ET (2000) Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 51:245\u2013270","journal-title":"Annu Rev Med"},{"key":"841_CR12","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.hoc.2007.08.010","volume":"21","author":"R Fonseca","year":"2007","unstructured":"Fonseca R, San Miguel J (2007) Prognostic factors and staging in multiple myeloma. Hematol Oncol Clin North Am 21:1115\u20131140","journal-title":"Hematol Oncol Clin North Am"},{"key":"841_CR13","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","volume":"23","author":"PR Greipp","year":"2005","unstructured":"Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Blade J, Boccadoro M, Child JA, Avet-Loiseau H, Kyle RA, Lahuerta JJ, Ludwig H, Morgan G, Powles R, Shimizu K, Shustik C, Sonneveld P, Tosi P, Turesson I, Westin J (2005) International staging system for multiple myeloma. J Clin Oncol 23:3412\u20133420","journal-title":"J Clin Oncol"},{"key":"841_CR14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2141.2003.04456.x","volume":"122","author":"JL Jacobson","year":"2003","unstructured":"Jacobson JL, Hussein MA, Barlogie B, Durie BG, Crowley JJ (2003) A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experience. Br J Haematol 122:441\u2013450","journal-title":"Br J Haematol"},{"key":"841_CR15","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1200\/JCO.2008.18.5082","volume":"26","author":"P Kapoor","year":"2008","unstructured":"Kapoor P, Snozek CLH, Colby C, Larson DR, Katzmann JA, Rajkumar SV, Greipp PR (2008) Clinical impact of discordance in serum albumin measurements on myeloma international staging system. J Clin Oncol 26:4051\u20134052","journal-title":"J Clin Oncol"},{"key":"841_CR16","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1006\/cimm.1995.1076","volume":"162","author":"A Lichtenstein","year":"1995","unstructured":"Lichtenstein A, Tu Y, Fady C, Vescio R, Berenson J (1995) Interleukin-6 inhibits apoptosis of malignant plasma cells. Cell Immunol 162:248\u2013255","journal-title":"Cell Immunol"},{"key":"841_CR17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000207722","volume":"60","author":"Y Matzner","year":"1978","unstructured":"Matzner Y, Benbassat J, Polliack A (1978) Prognostic factors in multiple myeloma: a retrospective study using conventional statistical methods and a computer program. Acta Haematol 60:257\u2013268","journal-title":"Acta Haematol"},{"issue":"6","key":"841_CR18","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/10245330701384161","volume":"12","author":"D Mihou","year":"2007","unstructured":"Mihou D, Katodritou E, Zervas K (2007) Multiple myeloma staging based on the combination of beta-2-microglobulin and albumin: The role of albumin in the model. Hematology 12(6):527\u2013531","journal-title":"Hematology"},{"key":"841_CR19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0895-4356(92)90081-W","volume":"45","author":"ME Salive","year":"1992","unstructured":"Salive ME, Cornoni-Huntley J, Phillips CL, Guralnik JM, Cohen HJ, Ostfeld AM, Wallace RB (1992) Serum albumin in older persons: relationship with age and health status. J Clin Epidemiol 45:213\u2013221","journal-title":"J Clin Epidemiol"},{"key":"841_CR20","doi-asserted-by":"crossref","first-page":"M71","DOI":"10.1093\/gerona\/56.2.M71","volume":"56","author":"DH Sullivan","year":"2001","unstructured":"Sullivan DH (2001) Guest editorial: what do the serum proteins tell us about our elderly patients? J Gerontol A Biol Sci Med Sci 56:M71\u201374","journal-title":"J Gerontol A Biol Sci Med Sci"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-009-0841-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-009-0841-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-009-0841-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T04:32:41Z","timestamp":1590208361000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-009-0841-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,21]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["841"],"URL":"https:\/\/doi.org\/10.1007\/s00277-009-0841-4","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,21]]}}}